CJC-1295 w/o DAC 10mg + Ipamorelin 10mg Peptides
Precision meets consistency in a balanced, lab-ready pairing of two widely studied GH secretagogues built for exacting research.
This CJC-1295 w/o DAC + Ipamorelin lyophilized research peptide vial delivers a composed, two-peptide profile for controlled study. Presented as a stable lyophilized powder (Peptide Lyophilized Vial), it is a non-flavored, bench-focused format designed for reliable handling. The total content is 20mg per vial, combining 10mg of CJC-1295 w/o DAC with 10mg of Ipamorelin for methodical, side-by-side or combined evaluation.
- 10mg CJC-1295 w/o DAC – Investigated for its engagement of growth hormone–releasing hormone receptor pathways and its support of pulsatile secretion characteristics in controlled models.
- 10mg Ipamorelin – Studied as a selective ghrelin receptor agonist with low off-target activity, often used to evaluate growth hormone release dynamics and comparative assay responses.
Designed for non-ingestible, laboratory applications, this vial supports consistent preparation and measured aliquoting in research settings. The lyophilized format enables controlled reconstitution with appropriate laboratory diluents, facilitating protocol development, assay standardization, and kinetic comparison work. Researchers value this pairing for investigating complementary pathways, building reference curves, and conducting repeatable analyses where stability, clarity, and predictable behavior matter.
Every vial reflects Better Molecule’s disciplined approach to quality. Produced in the United States within controlled environments, each lot is lot-coded for traceability and third-party tested for identity and purity to support confident, reproducible results. We prioritize clean handling, careful packaging, and transparent specifications so that laboratories can focus on data integrity over variables. This product is intended strictly for laboratory research use only. It is not a drug, not a food, and not for human or veterinary use or consumption.
Choose Better Molecule for peptides that align with professional expectations—measured, consistent, and backed by rigorous standards—so your work stays precise from vial to result.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Better Molecule are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
